Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Unger

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Nature Clinical Practice. Nephrology|November 7, 2007
Comparing the cerebroprotective properties of antihypertensive drugs in terms of their effects on angiotensinThomas Unger
MMW Fortschritte Der Medizin|July 9, 2008
["Hypertension 2008"]Thomas Unger
Medizinische Klinik (Munich, Germany : 1983)|May 2, 2006
[Innovation or pseudo-innovation: that is the question]Thomas Unger
The American Journal of Cardiology|June 5, 2003
The ongoing telmisartan alone and in combination with ramipril global endpoint trial programThomas Unger
Medizinische Klinik (Munich, Germany : 1983)|January 21, 2006
[Laudatio. On the presentation of the 2005 Robert Koch Award to the drug tiotropium bromide (spiriva)]Thomas Unger
The American Journal of Cardiology|February 12, 2002
The role of the renin-angiotensin system in the development of cardiovascular diseaseThomas Unger
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 30, 2003
Blood pressure lowering and renin-angiotensin system blockadeThomas Unger
Current Medical Research and Opinion|September 19, 2003
Inhibiting angiotensin receptors in the brain: possible therapeutic implicationsThomas Unger
Blood Pressure|April 21, 2017
Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan CilexetilThomas Unger
Nature Reviews. Nephrology|October 24, 2012
Risk factors: Plasma renin activity predicts renal impairmentThomas Unger
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Nature Clinical Practice. Nephrology|November 7, 2007
Comparing the cerebroprotective properties of antihypertensive drugs in terms of their effects on angiotensinThomas Unger
MMW Fortschritte Der Medizin|July 9, 2008
["Hypertension 2008"]Thomas Unger
Medizinische Klinik (Munich, Germany : 1983)|May 2, 2006
[Innovation or pseudo-innovation: that is the question]Thomas Unger
The American Journal of Cardiology|June 5, 2003
The ongoing telmisartan alone and in combination with ramipril global endpoint trial programThomas Unger
Medizinische Klinik (Munich, Germany : 1983)|January 21, 2006
[Laudatio. On the presentation of the 2005 Robert Koch Award to the drug tiotropium bromide (spiriva)]Thomas Unger
The American Journal of Cardiology|February 12, 2002
The role of the renin-angiotensin system in the development of cardiovascular diseaseThomas Unger
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 30, 2003
Blood pressure lowering and renin-angiotensin system blockadeThomas Unger
Current Medical Research and Opinion|September 19, 2003
Inhibiting angiotensin receptors in the brain: possible therapeutic implicationsThomas Unger
Blood Pressure|April 21, 2017
Differences Among Angiotensin II Type 1 Receptor Blockers: Characteristics of Candesartan CilexetilThomas Unger
Nature Reviews. Nephrology|October 24, 2012
Risk factors: Plasma renin activity predicts renal impairmentThomas Unger
Pageof 24